OnSight Medical ^Company

The digital transformation of healthcare is accelerating, with the COVID-19 outbreak demonstrating the rapidly growing need to enable healthcare professionals to quickly and efficiently diagnose patients, using tele-medicine, well before they arrive at the hospital. Handheld Ultrasound devices are a safe and cost-effective way of achieving quick assessment of the patient. However, the training required to use them is extremely long. It takes at least a year to become an expert. Hence, only experts are capable of performing a scan. The OnSight AI solution brings a new approach that is based on Geometrical Deep Learning, making ultrasound accessible to medical teams without prior training, thus enabling remote diagnostics anywhere and by anyone. OnSight GO is a software-only solution that can be installed on any portable handheld ultrasound device (device agnostic) enabling the healthcare professional to acquire a high-quality scan within minutes. It tackles two challenges. First, it navigates the clinician (e.g., think about WAZE for the human anatomy) to acquire the anatomical window for imaging and captures the images needed for diagnostic assessment. Secondly, it evaluates the status and function of the targeted area or organ automatically. The OnSight core technology is generic and can be deployed on different organs and imaging modalities. The first application to be introduced to market is cardiac scan and cardio-functional assessment. OnSight was founded by the Weizmann Institute of Science (Israel) and New York University (USA) based on state-of-the-art machine learning and artificial intelligence expertise.